Spirochlorphine (R-6890): in vitro characterization of its µ-opioid receptor potency and first report of a fatal intoxication

Purpose Novel synthetic opioids (NSOs) are among the most dangerous new psychoactive substances due to their high risk of overdose and respiratory depression. Since 2019, a group of NSOs known as “orphines” has emerged on the European market. Spirochlorphine (R-6890), first detected in 2024, is a structurally distinct NSO containing a spirotriazole core rather than the more common benzimidazole core. This study reports in vitro µ- opioid receptor potency, discusses the first fatal intoxication involving this compound and compares it to other NSOs. Methods The in vitro potency of spirochlorphine at the µ -opioid receptor (MOR) was assessed using a G-protein based receptor activation assay. Spirochlorphine concentrations in postmortem samples were determined using LC-MS/MS via a standard addition approach to compensate matrix effects. Urine samples were analyzed using external matrix calibration. Results In vitro, spirochlorphine demonstrated higher MOR potency than fentanyl, with a lower EC 50 of 8.3 nM compared to 12.2 nM. In the postmortem samples spirochlorphine was detected at 9.5 ng/mL in femoral blood, 64 ng/g in liver, 95 ng/g in kidney, and 57 µg (absolute) in stomach contents. Co-detections in femoral blood included desalkylflurazepam (250 ng/mL) and rilmazolam (25 ng/mL). Hair analysis revealed chronic exposure to benzodiazepines and opioids. Conclusion Spirochlorphine proved to be at least equally as potent as fentanyl. Hence, in the investigated case involving spirochlorphine, rilmazolam, and desalkylflurazepam with indicated benzodiazepine tolerance, death was mainly attributed to spirochlorphine. Accordingly a toxicological significance score (TSS) of 3 was assigned to spirochlorphine.

Authors

Institutions

Publication Details

Journal
International Journal of Legal Medicine
Published
2026-11-19
DOI
https://doi.org/10.1007/s00414-026-04070-y
Primary Topic
Forensic Toxicology and Drug Analysis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Spirochlorphine (R-6890): in vitro characterization of its µ-opioid receptor potency and first report of a fatal intoxication

Volker Auwärter, Lorenz M Bell, Laura M. Huppertz, Benedikt Pulver et al.
International Journal of Legal Medicine
Forensic Toxicology and Drug Analysis
article

Spirochlorphine (R-6890): in vitro characterization of its µ-opioid receptor potency and first report of a fatal intoxication

Volker Auwärter, Lorenz M Bell, Laura M. Huppertz, Benedikt Pulver, Sophia Wrbas
article en

Abstract

Purpose Novel synthetic opioids (NSOs) are among the most dangerous new psychoactive substances due to their high risk of overdose and respiratory depression. Since 2019, a group of NSOs known as “orphines” has emerged on the European market. Spirochlorphine (R-6890), first detected in 2024, is a structurally distinct NSO containing a spirotriazole core rather than the more common benzimidazole core. This study reports in vitro µ- opioid receptor potency, discusses the first fatal intoxication involving this compound and compares it to other NSOs. Methods The in vitro potency of spirochlorphine at the µ -opioid receptor (MOR) was assessed using a G-protein based receptor activation assay. Spirochlorphine concentrations in postmortem samples were determined using LC-MS/MS via a standard addition approach to compensate matrix effects. Urine samples were analyzed using external matrix calibration. Results In vitro, spirochlorphine demonstrated higher MOR potency than fentanyl, with a lower EC 50 of 8.3 nM compared to 12.2 nM. In the postmortem samples spirochlorphine was detected at 9.5 ng/mL in femoral blood, 64 ng/g in liver, 95 ng/g in kidney, and 57 µg (absolute) in stomach contents. Co-detections in femoral blood included desalkylflurazepam (250 ng/mL) and rilmazolam (25 ng/mL). Hair analysis revealed chronic exposure to benzodiazepines and opioids. Conclusion Spirochlorphine proved to be at least equally as potent as fentanyl. Hence, in the investigated case involving spirochlorphine, rilmazolam, and desalkylflurazepam with indicated benzodiazepine tolerance, death was mainly attributed to spirochlorphine. Accordingly a toxicological significance score (TSS) of 3 was assigned to spirochlorphine.

International Journal of Legal Medicine
University of Freiburg (DE), University Medical Center Freiburg (DE)
Forensic Toxicology and Drug Analysis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon